パチスロ撮影カメラ Release

Top
パチスロ撮影カメラ

Latest パチスロ撮影カメラ

May 9, 2012: Summary of Consolidated Financial パチスロ撮影カメラ(For the fiscal year ended March 31, 2012)
April 20, 2012: Launch of "AIPHAGANR Ophthalmic Solution 0.1%" for the treatment of Glaucoma / Ocular Hypertension, in Japan
February 3, 2012: Third Quarter Consolidated Financial パチスロ撮影カメラ for the Ending Fiscal Year March 31, 2012
February 3, 2012: Summary of Consolidated Financial パチスロ撮影カメラ(For the Third Quarter Ended December 31, 2011) [Japanese Standard]
November 8, 2011: パチスロ撮影カメラ Pharmaceutical and Daiichi Sankyo Brasil Reach Agreement in Brazil for Activities Related to the Development and Marketing of Imidafenacin
November 8, 2011: Summary of Consolidated Financial パチスロ撮影カメラ (For the Second Quarter Ended september 30,2011)［Japanese Standard］
November 8, 2011: Consolidated Financial パチスロ撮影カメラ (For the Second Quarter Ended september 30,2011)- Supplementary Information
August 22, 2011: First Quarter Consolidated Financial パチスロ撮影カメラ for the Fiscal Year Ending March 31, 2012
August 11, 2011: Summary of Consolidated Financial パチスロ撮影カメラ(For the First Quarter Ended June 30, 2011)
May 11, 2011: Financial パチスロ撮影カメラ for the Fiscal 2010, the Year Ended March 31, 2011- Supplementary Information
May 11, 2011: Summary of Consolidated Financial パチスロ撮影カメラ(For the fiscal year ended March 31, 2011)
April 5, 2011: Release of "Uritos® OD Tablets 0.1mg" a Drug for Overactive Bladder
February 24, 2011: パチスロ撮影カメラ signed a License Agreement with Almirall on COPD Therapeutic Agent "Aclidinium Bromide" for Japan Territory
February 21, 2011: パチスロ撮影カメラ Group's Participation in Environmental Hygiene
February 15, 2011: Third Quarter Consolidated Financial パチスロ撮影カメラ for the Fiscal Year Ending March 31, 2011
February 8, 2011: Summary of Consolidated Financial パチスロ撮影カメラ (For the Third Quarter Ended December 31, 2010) [Japanese Standard]
November 17, 2010: Summary of Consolidated Financial パチスロ撮影カメラ (For the Second Quarter Ended September 30,2010)[Japanese Standard]
November 12, 2010: Approval Received for Orally Disintegrating Tablet of imidafenacin (INN), a Drug for Overactive Bladder
November 8, 2010: Extension of License Rights Regarding KRP-203
September 21, 2010: Regarding Today's Media Report
July 30, 2010: First Quarter Consolidated Financial パチスロ撮影カメラ for the Fiscal Year Ending March 31, 2011
June 8, 2010: RELEASE OF "MUCODYNE® DS50%"
May 26, 2010: Change of Business Name
May 26, 2010: New Medium-Term Business Plan Developed: "HOPE 100 Stage 1"
February 3, 2010: Third Quarter Consolidated Financial パチスロ撮影カメラ for the Fiscal Year Ending March 31, 2010
January 18, 2010: MARKETING APPROVAL FOR "MUCODYNE® DS50%"
January 7, 2010: Application filed for Orally Disintegrating Tablet of imidafenacin (INN), a Drug for Overactive Bladder
November 5, 2009: Execution of License Agreement on Neramexane for Tinnitus with Merz Pharmaceuticals for Japan Territory
September 29, 2009: パチスロ撮影カメラ and Eisai Sign License Agreement for Development and Marketing of Uritos® Tablets in China, India, Sri Lanka and ASEAN Countries
August 5, 2009: First Quarter Consolidated Financial パチスロ撮影カメラ for the Fiscal Year Ending March 31, 2010
July 27, 2009: Grant of Marketing Right to Senju Pharmaceutical on Gatifloxacin Ophthalmic Solution in China
April 3, 2009: Change of Representative Director and President at パチスロ撮影カメラ Pharmaceutical
April 3, 2009: Change of Representative Director and President at パチスロ撮影カメラ
March 19, 2009: パチスロ撮影カメラ Announces Dissolution of Subsidiary
March 19, 2009: パチスロ撮影カメラ Subsidiary (Investment LPS) to Be Dissolved
February 27, 2009: Execution of Licensing and Supply Agreement on Uritos® Tablets with SPIMACO
February 5, 2009: Third Quarter Consolidated Financial パチスロ撮影カメラ for the Fiscal Year Ending March 31, 2009
February 4, 2009: パチスロ撮影カメラ Updates Credit Rating from R&I
January 29, 2009: Paper on Clinical Trial of MUCODYNE® for COPD Patients (PEACE Study) Chosen for THE LANCET Paper of the Year 2008
December 24, 2008: Approval for an additional regimen and dose of Pentasa®for the treatment of ulcerative colitis in its active phase
October 1, 2008: Launch of Ulcerative Colitis and Crohn's Disease Therapeutic Agent Pentasa Tablets 500
September 30, 2008: Discontinuation of Commercialization of Gatiflo(gatifloxacin) Tablets, a broad-spectrum antibacterial agent, in Japan
August 20, 2008: パチスロ撮影カメラ of Overseas Clinical Studies for KRP-104, anti-diabetes agent
April 22, 2008: Execution of License Agreement on Flutiform, an Anti-asthmatic Treatment, in Japan
April 18, 2008: Launch of KIPRES Tablets 5mg
March 3, 2008: Pentasa Tablets 250 Received Approvals For Additional Pediatric Indication
February 21, 2008: パチスロ撮影カメラ of Analysis of the OASIS Study,a Large-Scale Health-Related QOL Study in Patients with Chronic Cerebral Infarction
January 30, 2008: Execution of an Exclusive Patent License and Collaborative Research and Development Agreement with Merck & パチスロ撮影カメラ.,Inc. in the Field of Infectious Diseases
January 25, 2008: KIPRES Received Approvals for Additional Indication to Relieve Symptoms of Allergic Rhinitis
December 26, 2007: パチスロ撮影カメラ Obtains Credit Rating from R&I